key: cord-0705062-kb9uvqe4
authors: González, Jessica; Moncusí-Moix, Anna; Benitez, Ivan D.; Santisteve, Sally; Monge, Aida; Fontiveros, Maria Angeles; Carmona, Paola; Torres, Gerard; Barbé, Ferran; de Batlle, Jordi
title: Clinical consequences of COVID-19 lockdown in patients with COPD: results of a pre-post study in Spain
date: 2021-01-11
journal: Chest
DOI: 10.1016/j.chest.2020.12.057
sha: 188433c7ef0b8dd24a9a2ad6f44369b3b57ebd7f
doc_id: 705062
cord_uid: kb9uvqe4

nan

The Public Health response to COVID-19 pandemic has implied strict measures, including social distancing and self-protection enhancement, together with priority shifts in healthcare resources. Chronic patients have been specially affected by such measures. However, initial reports have shown reductions on the incidence of emergency conditions like myocardial infarction [1, 2] . Although data from Veterans Affairs Hospitals suggest a steep decrease in hospital admissions [3] , information for chronic obstructive pulmonary disease (COPD) exacerbations, is scarce. Therefore, we aimed to assess the impact of COVID-19 lockdown (consisting in the limitation of free movement except for acquiring food and medicines, seeking for healthcare, and attending work in essential services) on COPD exacerbations, symptoms and healthcare costs in a cohort of well-characterized Spanish COPD patients. This analysis is key, provided COPD exacerbations negatively impact health status, rates of hospitalization, and disease progression [4] .

Data from all COPD patients visiting the specialized pulmonary consultation of University Hospital Arnau de Vilanova (Lleida, Spain) in 2019 was collected retrospectively from electronic medical records (EMR). Telephonically administered surveys with standardized scripting were used to assess pulmonary symptoms (including mMRC dyspnea scale and COPD Assessment Test (CAT)), social and labor situation, lockdown enforcement (times leaving home per week), and number and type of COPD exacerbations during the lockdown period in Spain 

Of the 369 COPD patients that were visited during 2019, 24 patients had died since they last visit, 31 patients could not be contacted after 3 calls in different days, and 4 patients did not consent to participate. Finally, 310 COPD patients were included (mean (SD) age of 67 (8); 83% male; 79% former smokers; and, mean (SD) body mass index 28.5 (6) Kg/m 2 ). No significant differences were found in the characteristics of included and excluded patients. Spirometric measures prior to COVID-19 lockdown showed that the cohort had moderate to severe COPD (mean (SD) predicted percentage of forced expiratory volume in one second (FEV 1 ) 52% (19); total lung capacity (TLC) 92% (23); residual volume (RV) 145% (65); and, adjusted diffusing capacity for carbon monoxide (DLCO) 49% (19)). Most patients were classified as GOLD II (38%) or III (37%), with 37% in GOLD A and 21% in GOLD D, based on symptoms and exacerbations.

Most patients were retired (78%) and experienced a strong lockdown enforcement (56% of patients reporting not leaving home at all and 26% leaving home 3 or less times per week during the lockdown period). Table 1 shows the comparison of exacerbations and symptoms before and during the COVID-19 lockdown. A 62% decrease in the number of COPD exacerbations was observed.

Interestingly, this difference was focused in the number of moderate and severe exacerbations. Regarding symptoms, patients reported better overall CAT score ( Figure 1 ) and better scores in all of its dimensions (Table 1 ) during lockdown. In contrast, the severity of dyspnea worsened during lockdown, although this difference had little clinical relevance (+0.35 points on average). Finally, a 74% reduction in COPD-related healthcare costs was found.

The analysis of data from a well characterized cohort of COPD patients before and during COVID-19 lockdown suggests a significant reduction on COPD exacerbations, an improvement in symptoms, and a significant reduction in COPD-related healthcare costs. There are several J o u r n a l P r e -p r o o f possible explanations for these findings. First, as exacerbations are mainly triggered by respiratory viral infections or, to a lesser extent, bacterial infections and air pollution [5] , the combination of self-protection measures (social-distancing and use of face masks) and the decrease in air pollutants due to reduced human activities [6] , could have impacted positively on COPD exacerbations and symptoms. Next, patients' perception of vulnerability could have prompted a strict adherence to guidelines and good practices, as demonstrated by the high degree of lockdown enforcement reported in the cohort, or reports suggesting an improvement in asthma and COPD treatment adherence during the COVID-19 pandemic [7] .

Finally, the possibility of patients being afraid of seeking medical attention for COPD exacerbations during the COVID-19 pandemic should also be considered.

This study has several potential limitations: (i) not all subjects from the cohort could be contacted and reply the surveys; (ii) the pre-post design could be biased by seasonal trends, although the period Mars-May is usually fairly stable between years; (iii) the generalizability of the results to other countries could be dependent on the local healthcare setting and the characteristics of the applied lockdown measures; and, (iv) mMRC dyspnea scale and CAT were delivered face-to-face in 2019 but telephonically during the lockdown. However both tools were administered by the same professionals and are well-known to participants, and the mode of administration does not influence CAT scores or its psychometric properties [8] .

In conclusion, results suggest that the lockdown was associated with a reduction in COPD 

Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy

The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction

Admissions to Veterans Affairs Hospitals for Emergency Conditions During the COVID-19 Pandemic

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD Science Committee Report

Short-term Exposure to Ambient Fine Particulate Matter Increases Hospitalizations and Mortality in COPD: A Systematic Review and Meta-analysis

Air quality changes during the COVID-19

lockdown over the Yangtze River Delta Region: An insight into the impact of human activity pattern changes on air pollution variation

Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic

Does the COPD assessment test (CAT(TM)) questionnaire produce similar results when self-or interviewer administered?